The information contained in this announcement is deemed by the Company to constitute inside information as stipulated under the EU Market Abuse Regulation (596/2014). Upon publication of the announcement via a regulatory information service, this information is considered to be in the public domain.
23 February 2022
ASIMILAR GROUP PLC ('ASIMILAR' OR 'THE COMPANY')
Exercise of 240,000 Warrants, Issue of Equity and Total Voting Rights
Asimilar Group plc (AIM: ASLR), the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), hereby announces that the Company has received a subscription notice exercising warrants to subscribe for 240,000 new ordinary shares in the Company at a subscription price of 5 pence per share (the "New Shares").
Application will be made for the admission of the 240,000 New Shares to trading on AIM and it is expected that dealings in the New Shares will commence on or around 28 February 2022. On admission the New Shares will rank pari passu in all respects with the Company's existing ordinary shares.
Total Voting Rights
Following admission of the New Shares the total issued share capital of the Company will consist of 121,923,943 Ordinary Shares, each with voting rights. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.
-Ends-
Contacts
Asimilar Group plc | |
John Taylor, Non-Executive Chairman | via Buchanan |
| |
Cairn Financial Advisers LLP | |
Sandy Jamieson / Liam Murray | Tel: +44 20 7213 0880 |
| |
Peterhouse Capital Limited | |
Duncan Vasey / Lucy Williams | Tel: + 44 20 7220 9797 |
| |
Buchanan Communications Limited | |
Richard Oldworth / Chris Lane | Tel: +44 (0) 20 7466 5000 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.